Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as well as vaccine programs include LUNAR-COV19 and LUNAR-FLU. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines; Janssen Pharmaceuticals, Inc. to develop nucleic acid-based therapeutic candidates for the treatment of hepatitis B virus; Ultragenyx Pharmaceutical, Inc. to develop mRNA therapeutic candidates for rare disease targets; CureVac AG to develop mRNA therapeutic and vaccine candidates for various indications; Singapore Economic Development Board and Duke-NUS Medical School to develop LUNAR-COV19 vaccine; and Millennium Pharmaceuticals, Inc. to discover siRNA medicines for the treatment of non-alcoholic steatohepatitis. The company was founded in 2013 and is headquartered in San Diego, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Arcturus Therapeutics Holdings Inc..
Arcturus Therapeutics Holdings Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Arcturus Therapeutics Holdings Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Arcturus Therapeutics Holdings Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Arcturus Therapeutics Holdings Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Arcturus Therapeutics Holdings Inc. and all latest updates of the company are provided.
The 2025 version of Arcturus Therapeutics Holdings Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Arcturus Therapeutics Holdings Inc.- Key Facts
2.2 Arcturus Therapeutics Holdings Inc.- Geographic Locations
2.3 Arcturus Therapeutics Holdings Inc.- Subsidiaries and Affiliates
2.4 Arcturus Therapeutics Holdings Inc.- Business Divisions
2.5 Arcturus Therapeutics Holdings Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Arcturus Therapeutics Holdings Inc. Strategic Analysis Review
3.1 Arcturus Therapeutics Holdings Inc.- Key Strategies
3.2 Arcturus Therapeutics Holdings Inc.- Company Outlook Statement
3.3 Arcturus Therapeutics Holdings Inc.- SWOT Analysis
3.3.1 Arcturus Therapeutics Holdings Inc.- Key Strengths
3.3.2 Arcturus Therapeutics Holdings Inc.- Key Weaknesses
3.3.3 Arcturus Therapeutics Holdings Inc.- Potential Opportunities
3.3.4 Arcturus Therapeutics Holdings Inc.- Potential Threats
3.4 Arcturus Therapeutics Holdings Inc.- Key Competitors
4. Business Description of the Company
4.1 Arcturus Therapeutics Holdings Inc.- Business Overview
4.2 Arcturus Therapeutics Holdings Inc.- Operations by Segment
5 Products and Services Details
5.1 Arcturus Therapeutics Holdings Inc.- Key Products
5.2 Arcturus Therapeutics Holdings Inc.- Key Service Areas
5.3 Arcturus Therapeutics Holdings Inc.- Key Brands
6 Company Developments
6.1 Arcturus Therapeutics Holdings Inc.- Company History
6.2 Arcturus Therapeutics Holdings Inc.- Latest Developments
7 Financial Analysis
7.1 Arcturus Therapeutics Holdings Inc.- Income Statements
7.2 Arcturus Therapeutics Holdings Inc.- Balance Sheet
7.3 Arcturus Therapeutics Holdings Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Arcturus Therapeutics Holdings Inc.- Direct Competitors
8.2 Arcturus Therapeutics Holdings Inc.- Competitor Financial Ratios comparison
8.3 Arcturus Therapeutics Holdings Inc.- Competitor Stock Charts Comparison
8.4 Arcturus Therapeutics Holdings Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!